BDBM518578 US11124523, Example (+)-16

SMILES Fc1ccc(nc1)[C@]1(CCNCc2cccc(Cl)c2)CCO[C@]2(CCOC2)C1

InChI Key InChIKey=VDEAHPKUJXNLGH-FGZHOGPDSA-N

Data  1 KI  10 IC50  6 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 17 hits for monomerid = 518578   

TargetMu-type opioid receptor(Human)
Yantai University

Curated by ChEMBL
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataKi:  0.514nMAssay Description:Displacement of [3H]-Diprenorphine from human mu opiod receptor expressed in CHO cells incubated for 1 hr by competition binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Human)
Yantai University

Curated by ChEMBL
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataEC50: >3.00E+4nMAssay Description:Agonist activity at mu opioid receptor (unknown origin) assessed as beta arrestin-2 recruitment incubated for 3 days by PathHunter assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Human)
TBA

US Patent
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataIC50: >5.00E+4nMAssay Description:To test the inhibitory effects of the compounds of the present disclosure on different isoforms of human cytochrome P450 isoenzymesMore data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCytochrome P450 2C19(Human)
TBA

US Patent
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataIC50:  3.37E+4nMAssay Description:To test the inhibitory effects of the compounds of the present disclosure on different isoforms of human cytochrome P450 isoenzymesMore data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCytochrome P450 2D6(Human)
TBA

US Patent
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataIC50:  1.27E+4nMAssay Description:To test the inhibitory effects of the compounds of the present disclosure on different isoforms of human cytochrome P450 isoenzymesMore data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCytochrome P450 3A4(Human)
TBA

US Patent
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataIC50:  4.06E+4nMAssay Description:To test the inhibitory effects of the compounds of the present disclosure on different isoforms of human cytochrome P450 isoenzymesMore data for this Ligand-Target Pair
In DepthDetails US Patent

LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataIC50:  2.28E+4nMAssay Description:To test the blocking effects of the compounds of the present disclosure on hERG potassium currents.More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetMu-type opioid receptor(Human)
Yantai University

Curated by ChEMBL
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataEC50:  0.350nMAssay Description:Agonist activity at mu opioid receptor (unknown origin) assessed as increase in cAMP level incubated for 40 mins by spectrophotometryMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 1A2(Human)
Yantai University

Curated by ChEMBL
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Human)
TBA

US Patent
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C19(Human)
TBA

US Patent
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataIC50: >3.30E+4nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataIC50:  2.28E+4nMAssay Description:Inhibition of human ERG expressed in CHO cells at holding potential of -80 mV by whole cell patch clamp assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Human)
Yantai University

Curated by ChEMBL
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataEC50:  5.10nMAssay Description:Agonist activity at human mu opioid receptor expressed in HEK293 assessed as increase in calcium mobilization incubated for 60 mins by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Human)
Yantai University

Curated by ChEMBL
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human delta opioid receptor expressed in HEK293 assessed as increase in calcium mobilization incubated for 60 mins by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Human)
Yantai University

Curated by ChEMBL
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human kappa opioid receptor expressed in HEK293 assessed as increase in calcium mobilization incubated for 60 mins by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Human)
Yantai University

Curated by ChEMBL
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataEC50:  0.5nMAssay Description:The experiment was performed using a cAMP detection kit from Cisbio (Cisbio #62AM4PEJ).More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetCytochrome P450 1A2(Rat)
TBA

US Patent
LigandPNGBDBM518578(US11124523, Example (+)-16)
Affinity DataIC50: >5.00E+4nMAssay Description:To test the inhibitory effects of the compounds of the present disclosure on different isoforms of human cytochrome P450 isoenzymesMore data for this Ligand-Target Pair
In DepthDetails US Patent